Genomics and Immunomics in the Treatment of Urothelial Carcinoma.

Curr Oncol · 2022 · PMC9139747 · PMID 35621673

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

The study did not meet the primary endpoint of PFS in the intention-to-treat population, but there seems to be a positive trend in HRR-mutated patients (median PFS 5.6 months in the experimental group and 1.8 months in the control group) [ 71 ] ( Table 2 ). 2.9.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.